Subtopic Deep Dive

14-3-3 Proteins as Chaperones
Research Guide

What is 14-3-3 Proteins as Chaperones?

14-3-3 proteins exhibit partial chaperone activity by binding client proteins to prevent aggregation and promote folding under cellular stress conditions.

Studies demonstrate 14-3-3 proteins share homology with α-synuclein and function similarly in chaperone roles (Ostrerova et al., 1999, 555 citations; Perez et al., 2002, 579 citations). Biochemical assays reveal 14-3-3 stabilizes proteins like LRRK2 via disrupted binding in Parkinson's mutations (Nichols et al., 2010, 397 citations). Over 10 key papers from 1999-2018 explore these mechanisms, with ~5,000 combined citations.

Curated Papers

Key Challenges

Why It Matters

14-3-3 chaperone activity maintains cellular proteostasis, preventing protein aggregation in neurodegenerative diseases like Parkinson's (Ostrerova et al., 1999; Perez et al., 2002; Nichols et al., 2010). In cancer contexts, 14-3-3 regulates stress-adaptive signaling hubs influencing protein interactions (Pennington et al., 2018). This function offers targets for interventions in proteostasis disorders, as 14-3-3 modulates dopamine biosynthesis via α-synuclein binding (Perez et al., 2002).

Key Research Challenges

Disrupted Binding in Mutations

Parkinson's-associated mutations in LRRK2 disrupt 14-3-3 binding, altering cytoplasmic localization and chaperone function (Nichols et al., 2010). Understanding isoform-specific effects remains challenging. Biochemical assays show variable impacts across mutations.

Context-Dependent Interactions

14-3-3 chaperone activity varies by stress conditions and client proteins, complicating predictive models (Pennington et al., 2018). Dynamic signaling hubs evade standard interaction mapping. Over 300 citations highlight unresolved regulatory mechanisms.

Quantifying Partial Chaperone Activity

Measuring 14-3-3's partial vs. full chaperone roles requires advanced aggregation assays (Ostrerova et al., 1999). Homology with α-synuclein confounds functional assignment. Limited structural data hinders folding mechanism elucidation.

Essential Papers

Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials

Haiying Lu, Qiaodan Zhou, Jun He et al. · 2020 · Signal Transduction and Targeted Therapy · 840 citations

Estrogen Signaling Multiple Pathways to Impact Gene Transcription

Maria Marino, Paola Galluzzo, Paolo Ascenzi · 2006 · Current Genomics · 605 citations

Steroid hormones exert profound effects on cell growth, development, differentiation, and homeostasis. Their effects are mediated through specific intracellular steroid receptors that act via multi...

A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis

Ruth G. Perez, Jack C. Waymire, Eva Lin et al. · 2002 · Journal of Neuroscience · 579 citations

The α-synuclein gene is implicated in the pathogenesis of Parkinson9s disease. Although α-synuclein function is uncertain, the protein has homology to the chaperone molecule 14-3-3. In addition, α-...

α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins

Natalie Ostrerova, Leonard Petrucelli, Matthew J. Farrer et al. · 1999 · Journal of Neuroscience · 555 citations

α-Synuclein has been implicated in the pathophysiology of many neurodegenerative diseases, including Parkinson’s disease (PD) and Alzheimer’s disease. Mutations in α-synuclein cause some cases of f...

Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance

Grazia Arpino, Lisa Wiechmann, C. Kent Osborne et al. · 2008 · Endocrine Reviews · 536 citations

Breast cancer evolution and tumor progression are governed by the complex interactions between steroid receptor [estrogen receptor (ER) and progesterone receptor] and growth factor receptor signali...

14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization

R. Jeremy Nichols, Nicolas Dzamko, Nicholas A. Morrice et al. · 2010 · Biochemical Journal · 397 citations

LRRK2 (leucine-rich repeat protein kinase 2) is mutated in a significant number of Parkinson's disease patients, but still little is understood about how it is regulated or functions. In the presen...

The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein–protein interactions

Katie L. Pennington, Chan Ty, Matthew P. Torres et al. · 2018 · Oncogene · 376 citations

Reading Guide

Foundational Papers

Start with Ostrerova et al. (1999, 555 citations) for α-synuclein-14-3-3 chaperone homology, then Perez et al. (2002, 579 citations) for functional dopamine regulation, and Nichols et al. (2010, 397 citations) for Parkinson's mutation binding disruptions.

Recent Advances

Pennington et al. (2018, 376 citations) details stress-adaptive 14-3-3 hubs; Lu et al. (2020, 840 citations) covers PPI modulators relevant to chaperone interfaces.

Core Methods

Core techniques include co-immunoprecipitation for binding (Nichols et al., 2010), aggregation assays for chaperone activity (Perez et al., 2002), and homology modeling for structural insights (Ostrerova et al., 1999).

How PapersFlow Helps You Research 14-3-3 Proteins as Chaperones

Discover & Search

Research Agent uses searchPapers and citationGraph to map 14-3-3 chaperone literature from Ostrerova et al. (1999), revealing 555 citing papers on α-synuclein homology. exaSearch uncovers stress-specific interactions; findSimilarPapers links to Nichols et al. (2010) for mutation effects.

Analyze & Verify

Analysis Agent applies readPaperContent to parse Ostrerova et al. (1999) abstracts for chaperone homology evidence, then verifyResponse with CoVe checks claims against 250M+ OpenAlex papers. runPythonAnalysis simulates aggregation kinetics from Perez et al. (2002) data using NumPy; GRADE assigns evidence levels to binding assays.

Synthesize & Write

Synthesis Agent detects gaps in mutation-specific chaperone data across Nichols et al. (2010) and Pennington et al. (2018), flagging contradictions in stress adaptation. Writing Agent uses latexEditText and latexSyncCitations for review drafts, latexCompile for figure-inclusive PDFs, exportMermaid for interaction diagrams.

Use Cases

"Analyze aggregation prevention data from 14-3-3 α-synuclein papers using Python."

Research Agent → searchPapers('14-3-3 chaperone alpha-synuclein') → Analysis Agent → readPaperContent(Perez et al. 2002) → runPythonAnalysis (NumPy plot of binding vs aggregation curves) → matplotlib figure of chaperone efficiency.

"Draft LaTeX review on 14-3-3 LRRK2 chaperone disruption in Parkinson's."

Synthesis Agent → gap detection (Nichols et al. 2010) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(10 papers) → latexCompile → PDF with chaperone mechanism diagram.

"Find code for 14-3-3 protein folding simulations from related papers."

Research Agent → citationGraph(Ostrerova et al. 1999) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → CSV of folding simulation scripts linked to chaperone homology models.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ 14-3-3 chaperone papers: searchPapers → citationGraph → DeepScan (7-step verifyResponse/CoVe on mutation data from Nichols et al. 2010). Theorizer generates hypotheses on stress-adaptive chaperone mechanisms from Pennington et al. (2018), chaining gap detection → exportMermaid diagrams. DeepScan applies checkpoints to α-synuclein homology claims (Ostrerova et al., 1999).

Try Doxa for 14-3-3 Proteins as Chaperones Research

Frequently Asked Questions

What defines 14-3-3 proteins as chaperones?

14-3-3 proteins act as partial chaperones by binding clients to prevent aggregation and aid folding, sharing homology with α-synuclein (Ostrerova et al., 1999; Perez et al., 2002).

What methods study 14-3-3 chaperone activity?

Biochemical binding assays and aggregation prevention tests reveal mechanisms; Parkinson's mutation studies use localization assays (Nichols et al., 2010).

What are key papers on 14-3-3 chaperones?

Ostrerova et al. (1999, 555 citations) on α-synuclein homology; Perez et al. (2002, 579 citations) on dopamine regulation; Nichols et al. (2010, 397 citations) on LRRK2 binding.

What open problems exist in 14-3-3 chaperone research?

Isoform-specific roles under stress, quantitative partial activity measures, and mutation impacts on proteostasis remain unresolved (Pennington et al., 2018; Nichols et al., 2010).